Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Forza Innovations's operating cash flow per share for the
three
months ended in Dec. 2023 was $0.00.
Forza Innovations's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Forza Innovations's Operating Cash Flow per Share or its related term are showing as below:
FORZ's 3-Year OCF Growth Rate is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 12.1 * Ranked among companies with meaningful 3-Year OCF Growth Rate only.
Forza Innovations Operating Cash Flow per Share Related Terms
Forza Innovations Operating Cash Flow per Share Historical Data
* Premium members only.
The historical data trend for Forza Innovations's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Forza Innovations Operating Cash Flow per Share Chart
FORZ vs USAQ, EMED, RTSL: Operating Cash Flow per Share Comparison
For the Medical Devices subindustry, Forza Innovations's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Forza Innovations Price-to-Operating-Cash-Flow vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Forza Innovations's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Forza Innovations's Price-to-Operating-Cash-Flow falls into.
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Operating Cash Flow per Share of $0.00 mean?
Forza Innovations (FORZ) has a Operating Cash Flow per Share of $0.00 as of Dec. 2023. Operating cash flow per share equals the per-share amount of cash flow from operations. View historical data on Forza Innovations and its competitors.
Is Forza Innovations' Operating Cash Flow per Share too high?
Forza Innovations' current Operating Cash Flow per Share is $0.00.
How does Forza Innovations' Operating Cash Flow per Share compare to USAQ and EMED?
Forza Innovations' Operating Cash Flow per Share of $0.00 can be compared against companies in the Medical Devices & Instruments industry. The industry median Operating Cash Flow per Share is 12.10. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Cash Flow per Share for a Medical Devices & Instruments company?
The median Operating Cash Flow per Share among Medical Devices & Instruments companies is 12.10, based on 649 companies in the industry. Companies in the top quartile (top 25%) have a Operating Cash Flow per Share significantly above this median, while those in the bottom quartile fall well below. However, Operating Cash Flow per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Cash Flow per Share mean?
A high Operating Cash Flow per Share can signal that a stock is expensive relative to its fundamentals. Operating cash flow per share equals the per-share amount of cash flow from operations. View historical data on Forza Innovations and its competitors. For the Medical Devices & Instruments industry, the median Operating Cash Flow per Share is 12.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Forza Innovations's current Operating Cash Flow per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Forza Innovations stock overvalued right now?
Forza Innovations (FORZ) has a current Operating Cash Flow per Share of $0.00. The current Operating Cash Flow per Share is $0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Cash Flow per Share calculated?
Operating Cash Flow per Share is calculated from a company's financial statements. For Forza Innovations (FORZ), the current Operating Cash Flow per Share is $0.00 as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Forza Innovations Inc is in the health-tech wearable performance business. The company has acquired all the ownership and rights to certain late developmental-stage products, including the J4 Sport, J4 X, and J4 Fitbelt. These products are wearable back compression devices, used to relax, warm up, loosen, or relax stiff & sore muscles. The therapeutic application of heat causes a change in the temperature of the soft tissues which decreases joint stiffness and relieves inflammation.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FORZ has been successfully added to your 
